Sonoma Orthopedic Products, a Santa Rosa, Calif.-based commercial orthopedic trauma company focused on minimally invasive repair of fractured bone, has closed a $22m Series D financing round.
The round was led by Ascension Health Ventures (AHV), with participation from Split Rock Partners, Legacy Life Sciences, EDF Ventures, MedVenture Associates, DFJ InCube Ventures, Emergent Medical Partners, and Asset Management Partners.
The company intends to use the funds to launch new products, expand its U.S. sales network, key clinical trials, and acquire certain key assets of NovaLign Orthopaedics, Inc.
In conjunction with the financing, Dr. Walter Lin of AHV has joined Sonoma’s board of directors.
Founded by COO Charles Nelson and led by President and CEO Glen Coleman, the company uses its proprietary technology to develop and commercialize least invasive, fracture specific implant systems for addressing problematic fractures.